Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer Case Study Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…CertaraOctober 2, 2025
37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT) Conference 37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT) CertaraSeptember 22, 2025
Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science Announcement Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…CertaraSeptember 22, 2025
Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool Announcement Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool RADNOR, Pa. – September 17, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraSeptember 17, 2025
FAQs on Developing EMA Policy 0070 Submissions Blog FAQs on Developing EMA Policy 0070 Submissions This blog answers audience questions posed during our RAPS webinar, How to Plan for a…CertaraSeptember 15, 2025
Top 10 Things to Know About ADNCA for Non-Compartmental Analysis Guide Top 10 Things to Know About ADNCA for Non-Compartmental Analysis Learn how to transition from non-standard ADPC datasets to the CDISC ADNCA ADaM standard. Improve…CertaraSeptember 11, 2025
Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research Press Coverage Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…Danielle PillsburySeptember 10, 2025
AI-driven drug discovery picks up as FDA pushes to reduce animal testing Press Coverage AI-driven drug discovery picks up as FDA pushes to reduce animal testing AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…CertaraSeptember 9, 2025
Redefining Every Stage of Investment (RESI) Seed to Exit Conference Redefining Every Stage of Investment (RESI) Seed to Exit –CertaraSeptember 5, 2025
Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise Case Study Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise Learn how Certara's project management team helped a large biotech streamline the development and updates…CertaraSeptember 5, 2025